Regulatory

Latest News

FDA Approves Johnson & Johnson’s Varipulse for Drug-Resistant Paroxysmal Atrial Fibrillation
FDA Approves Johnson & Johnson’s Varipulse for Drug-Resistant Paroxysmal Atrial Fibrillation

November 8th 2024

The Varipulse platform includes a single-device workflow with minimal to zero fluoroscopy requirements, real-time imaging, and lesion tagging for paroxysmal atrial fibrillation.

Eisai Completes Rolling Biologics License Application to FDA for Subcutaneous Maintenance Dosing Option of Leqembi for Alzheimer Disease
Eisai Completes Rolling Biologics License Application to FDA for Subcutaneous Maintenance Dosing Option of Leqembi for Alzheimer Disease

November 1st 2024

FDA Grants Accelerated Approval to Novartis’ Scemblix for Newly Diagnosed Chromosome-Positive Chronic Myeloid Leukemia
FDA Grants Accelerated Approval to Novartis’ Scemblix for Newly Diagnosed Chromosome-Positive Chronic Myeloid Leukemia

October 30th 2024

FDA Approves Protega Pharmaceuticals’ Roxybond for Severe Pain Management
FDA Approves Protega Pharmaceuticals’ Roxybond for Severe Pain Management

October 29th 2024

MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?

October 25th 2024

More News